HCC

Latest News

Key Factors for Choosing Frontline Hepatocellular Carcinoma Therapy
Key Factors for Choosing Frontline Hepatocellular Carcinoma Therapy

March 19th 2023

During a Targeted Oncology™ Case-Based Roundtable™ event, Daneng Li, MD, discussed the available therapy options for a patient with advanced hepatocellular carcinoma.

Finn Reviews Phase 3 Trials of Lenvatinib  in Advanced HCC
Finn Reviews Phase 3 Trials of Lenvatinib in Advanced HCC

March 14th 2023

Phase 1 Trial of JWATM214 Initiates in GPC-3-Expressing Hepatocellular Carcinoma
Phase 1 Trial of JWATM214 Initiates in GPC-3-Expressing Hepatocellular Carcinoma

March 2nd 2023

Novel CEACAM Antibody Lands FDA Orphan Drug Designation for HCC
Novel CEACAM Antibody Lands FDA Orphan Drug Designation for HCC

March 1st 2023

Determining Need for Biopsy in Suspected Hepatocellular Carcinoma
Determining Need for Biopsy in Suspected Hepatocellular Carcinoma

February 27th 2023

Video Series
Video Interviews

More News